Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
An Open Label Expanded Access Study of Omidubicel, for Allogeneic Transplantation in Patients with Hematological Malignancies
Clinical Trial Grant
Duke Scholars
Principal Investigator
Mitchell Eric Horwitz
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Gamida Cell Ltd
Start Date
June 1, 2020
End Date
May 31, 2025
Awarded By
Gamida Cell Ltd
Start Date
June 1, 2020
End Date
May 31, 2025
